Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells

Background: Lung cancer remains a leading cause of cancer-related death, with an annual global mortality rate of 18.4%. Despite advances in diagnostic and therapeutic technologies, non–small cell lung carcinoma (NSCLC) continues to be characterized by a poor prognosis. This may be associated with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiong, Tung-Yu, Weng, Pei-Wei, Wang, Chun-Hua, Setiawan, Syahru Agung, Yadav, Vijesh Kumar, Pikatan, Narpati Wesa, Fong, Iat-Hang, Yeh, Chi-Tai, Hsu, Chia-Hung, Kuo, Kuang-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266857/
https://www.ncbi.nlm.nih.gov/pubmed/35806291
http://dx.doi.org/10.3390/ijms23137283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266857/
https://www.ncbi.nlm.nih.gov/pubmed/35806291
http://dx.doi.org/10.3390/ijms23137283

Ejemplares similares